Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$817,343,396
-$35,718,519 QoQ
Shares Held
6,360,649
-10.3% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#45
of 3,769 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. MRK ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in MRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $817,343,396 | 6,360,649 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $853,061,915 | 7,091,711 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $805,414,887 | 7,651,671 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $700,322,495 | 8,344,126 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $623,366,475 | 7,874,766 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $762,081,660 | 7,660,652 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $855,119,404 | 7,530,111 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $672,780,824 | 5,434,417 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $724,776,410 | 5,492,811 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $590,731,847 | 5,418,564 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $494,824,130 | 4,806,451 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $529,023,224 | 4,584,654 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $544,650,199 | 5,119,374 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $561,136,725 | 5,057,564 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $408,091,934 | 4,738,643 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $458,447,706 | 5,028,493 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $405,115,064 | 4,937,417 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $374,448,784 | 4,885,814 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $367,796,319 | 4,896,769 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $373,565,161 | 4,803,461 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $350,163,782 | 4,542,270 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||